US Broker Ratings

EyePoint, Inc. (EYPT) Stock Analysis: Exploring a 145% Potential Upside in the Biotech Sector

EyePoint, Inc. (NASDAQ: EYPT) is capturing the attention of investors with its significant growth potential in the biotechnology sector. Specializing in the development and commercialization of innovative therapeutics for serious..

Myriad Genetics, Inc. (MYGN): Investor Outlook on a Healthcare Innovator with 85% Upside Potential

Myriad Genetics, Inc. (NASDAQ: MYGN), a key player in the healthcare sector, continues to capture attention in the diagnostics and research industry. As the company navigates a challenging financial landscape,..

CorMedix Inc. (CRMD) Stock Analysis: Potential Upside of Over 100% Amidst Robust Revenue Growth

CorMedix Inc. (NASDAQ: CRMD), a biopharmaceutical company headquartered in Berkeley Heights, New Jersey, is catching the attention of investors with its substantial revenue growth and an impressive potential upside. Operating..

Sionna Therapeutics, Inc. (SION) Stock Analysis: A High-Stakes Bet on Biotech Innovation with 20.13% Upside Potential

Sionna Therapeutics, Inc. (SION), a clinical-stage biopharmaceutical company, stands at the forefront of innovation in the biotechnology sector, focusing on groundbreaking treatments for cystic fibrosis (CF). With a market capitalization..

iRadimed Corporation (IRMD) Stock Analysis: A High-Growth Medical Device Leader with an 18.98% Upside

Investors seeking exposure to the robust healthcare sector may find iRadimed Corporation (NASDAQ: IRMD) an intriguing opportunity. As a leader in the niche market of MRI-compatible medical devices, iRadimed presents..

Collegium Pharmaceutical, Inc. (COLL) Stock Analysis: 18.78% Potential Upside Beckons Investors

Collegium Pharmaceutical, Inc. (NASDAQ: COLL), a formidable player in the healthcare sector, has been making waves in the specialty and generic drug manufacturing industry. This U.S.-based company, with a market..

Tilray Brands, Inc. (TLRY) Stock Analysis: Potential Upside of Nearly 50% Amidst Mixed Performance Indicators

Tilray Brands, Inc. (NASDAQ: TLRY) is a prominent player in the healthcare sector, specifically within the drug manufacturing industry focusing on specialty and generic products. As a Canadian company, Tilray..

Ginkgo Bioworks Holdings, Inc. (DNA): Investor Outlook on a Biotechnology Innovator with a 3.20% Potential Upside

Ginkgo Bioworks Holdings, Inc. (NYSE: DNA) stands as a beacon of innovation in the biotechnology sector, representing a forward-thinking approach to cell programming and biosecurity. With a market capitalization of..

Avanos Medical, Inc. (AVNS) Stock Analysis: Navigating Challenges with a Strong Free Cash Flow

Avanos Medical, Inc. (NYSE: AVNS) operates within the healthcare sector, focusing specifically on medical devices. This Alpharetta, Georgia-based company has carved out a niche for itself by offering innovative medical..

Zevra Therapeutics, Inc. (ZVRA) Investor Outlook: Exploring a Potential 153.59% Upside

Zevra Therapeutics, Inc. (NASDAQ: ZVRA) is making waves in the biotech sector with its focus on pioneering treatments for rare diseases. With a market capitalization of $500.49 million, this Florida-based..

Autolus Therapeutics plc (AUTL): Unpacking the Potential 448% Upside for Investors

Autolus Therapeutics plc (NASDAQ: AUTL) has recently captured investor attention, not just for its innovative approach in the biotechnology sector but also due to its staggering potential upside of 448.17%...

Fortrea Holdings Inc. (FTRE) Stock Analysis: A Potential 49% Upside Beckons Investors

Fortrea Holdings Inc. (FTRE), a prominent player within the biotechnology sector, is capturing investor attention with its promising growth prospects and strategic collaborations. Based in Durham, North Carolina, Fortrea is..

SIGA Technologies Inc. (SIGA) Stock Analysis: Intriguing Valuation Metrics Amidst Revenue Challenges

SIGA Technologies Inc. (NASDAQ: SIGA), a key player in the healthcare sector specializing in drug manufacturing, presents a curious case for investors. With a market capitalization of approximately $484.81 million,..

Day One Biopharmaceuticals, Inc (DAWN) Stock Analysis: A Potential 91.59% Upside in the Biotechnology Sector

Day One Biopharmaceuticals, Inc. (NASDAQ: DAWN), a dynamic player in the biotechnology sector, has recently caught the attention of investors with a potential upside of 91.59%. The company, valued at..

Amylyx Pharmaceuticals (AMLX) Stock Analysis: A 50% Upside Opportunity in the Neurodegenerative Disease Market

Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) has been capturing the attention of investors with its potential to deliver significant upside, despite its current challenges. Operating within the fast-evolving healthcare sector, Amylyx..

LENZ Therapeutics, Inc. (LENZ) Stock Analysis: A Promising Biotech with a 325% Potential Upside

In the dynamic world of biotechnology, few companies present as intriguing a case for investors as LENZ Therapeutics, Inc. (NASDAQ: LENZ). With its focus on developing innovative therapies to improve..

OrthoPediatrics Corp. (KIDS) Stock Analysis: Exploring a 40.76% Potential Upside in Pediatric Orthopedics

OrthoPediatrics Corp. (NASDAQ: KIDS), a specialized medical device company, is making waves in the healthcare sector with its unique focus on pediatric orthopedic solutions. With a market capitalization of $427.57..

Maze Therapeutics, Inc. (MAZE) Stock Analysis: A Biotech with a 9.78% Upside Potential

Maze Therapeutics, Inc. (NASDAQ: MAZE) represents a compelling opportunity within the biotechnology sector, particularly for those interested in pioneering healthcare innovations. With a market capitalization of $2.17 billion, Maze operates..

Simulations Plus, Inc. (SLP) Stock Analysis: Exploring a Potential 102% Upside Opportunity

Simulations Plus, Inc. (NASDAQ: SLP), a healthcare sector player specializing in health information services, is garnering attention with its potential 102% upside based on current analyst ratings. As a prominent..

RxSight, Inc. (RXST) Stock Analysis: A Closer Look at the 23.68% Potential Upside

RxSight, Inc. (RXST), a notable player in the healthcare sector, is making waves in the medical devices industry with its innovative approach to enhancing cataract surgery outcomes. Headquartered in Aliso..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds